Kassenov M 1
1. Breaking the Barrier: SARS-CoV-2 Infections in Wild and Companion Animals and Their Implications for Public Health
2. Phylogenetic analysis of prospective M. bovis antigens with the aim of developing candidate vaccines for bovine tuberculosis
3. Safety and Protective Efficacy of a Candidate Vector-Based Vaccine for Bovine Tuberculosis
4. Serological surveillance of Trypanosoma evansi in Kazakhstani camels by complement fixation and formalin gel tests
5. Bovine Viral Diarrhea in Kazakhstan
6. Coding Complete Genome Sequence of the SARS-CoV-2 Virus Strain, Variant B.1.1, Sampled from Kazakhstan
7. Complete Coding Genome Sequence of an Influenza A/H3N8 Equine Virus Isolated in Kazakhstan in 2007
8. A New Intranasal Influenza Vector-Based Vaccine TB/FLU-04L Against Tuberculosis: Preclinical Safety Studies
9. Serological and molecular surveillance of infectious bovine rhinotracheitis in Kazakhstan
10. Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up
11. SARS-CoV-2 Delta Variant Does Not Sustain Replication in Companion Dogs: Insights from an Experimental Infection Model
12. Seroprevalence and Molecular Analysis of Bovine Leukemia Virus in Kazakhstan
13. First report on identification of Salmonella Abortusovis from ovine abortion cases in Kazakhstan
14. Blackleg in cattle in Kazakhstan: regional epizootology, seasonal patterns, and molecular identification of the pathogen
15. Applications and Advancements of Animal Cell Cultures in Virology: Insights from Lumpy Skin Disease Virus Research
16. A novel influenza vector-based vaccine expressing ESAT-6 and TB10.4 confers immunity and protection against Bovine tuberculosis in guinea pigs and calves
17. Complete genome sequence of SARS-CoV-2 isolated from a dog in Kazakhstan
18. Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19
19. Evaluation of a novel real-time polymerase chain reaction assay for identifying H3 equine influenza virus in Kazakhstan
20. Pre-Clinical Safety and Immunogenicity Study of a Coronavirus Protein-Based Subunit Vaccine for COVID-19
21. Preclinical Evaluation of TB/FLU-04L—An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis
22. Development and evaluation of a multiplex polymerase chain reaction in real-time for differential diagnosis of Moraxella-induced keratoconjunctivitis in livestock
23. Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan
24. Development and Evaluation of a Live Attenuated Egg-Based Camelpox Vaccine
25. Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters
1